ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Henry Neil, Natcher’s right arm, Back In The Job

March 25, 1988

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999